Representative Lloyd Doggett (D-Texas) recently bought shares of The Procter & Gamble Company (NYSE:PG). In a filing disclosed on December 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in Procter & Gamble stock on November 15th.
Representative Lloyd Doggett also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Coca-Cola (NYSE:KO) on 10/1/2024.
- Purchased $1,001 – $15,000 in shares of PPG Industries (NYSE:PPG) on 9/12/2024.
- Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/12/2024.
- Purchased $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 9/10/2024.
- Purchased $1,001 – $15,000 in shares of International Business Machines (NYSE:IBM) on 9/10/2024.
Procter & Gamble Trading Up 0.5 %
NYSE:PG opened at $176.07 on Friday. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $180.43. The business’s 50-day simple moving average is $170.75 and its 200 day simple moving average is $169.34. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market cap of $414.65 billion, a price-to-earnings ratio of 30.36, a price-to-earnings-growth ratio of 3.78 and a beta of 0.44.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares in the company, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 83,080 shares of company stock valued at $14,629,038 in the last quarter. Company insiders own 0.18% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have commented on PG shares. Piper Sandler started coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, Morgan Stanley lifted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $180.45.
Check Out Our Latest Research Report on Procter & Gamble
Hedge Funds Weigh In On Procter & Gamble
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble during the second quarter valued at $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble in the second quarter worth approximately $29,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of Procter & Gamble during the third quarter worth approximately $33,000. POM Investment Strategies LLC acquired a new position in Procter & Gamble in the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth approximately $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
About Representative DOGGETT
Lloyd Doggett (Democratic Party) is a member of the U.S. House, representing Texas’ 37th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2025. Doggett (Democratic Party) is running for re-election to the U.S. House to represent Texas’ 37th Congressional District. He declared candidacy for the Democratic primary scheduled on March 5, 2024. In the 116th Congress, Doggett served on the House Ways & Means Committee, and he co-founded the House Prescription Drug Taskforce. Doggett began his political career in the Texas State Senate, where he served from 1973 to 1985. He then served as a member of the Texas Supreme Court from 1989 until 1994. He represented Texas’ 25th Congressional District from 2005 to 2013 and Texas’ 10th Congressional District from 1995 to 2005. As of a 2014 analysis of multiple outside rankings, Doggett is an average Democratic member of Congress, meaning he will vote with the Democratic Party on the majority of bills. Lloyd Doggett was born in Austin, Texas. Doggett graduated from Austin High School in 1964. He earned a B.A. from the University of Texas at Austin in 1967 and a J.D. from the University of Texas in 1970. Doggett’s career experience includes working as an adjunct professor with the University of Texas School of Law.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- Golden Cross Stocks: Pattern, Examples and Charts
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How to Capture the Benefits of Dividend Increases
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.